Newstral
Article
Ddailyvoiceplus.com on 2019-05-08 16:10
Boehringer Ingelheim subject of class action suit over asthma inhaler
Related news
- Boehringer Ingelheim cites COPD progresswestfaironline.com
- Boehringer Ingelheim, Sanofi targeted in class-action suit over Zantacwestfaironline.com
- DBoehringer Ingelheim settles litigation over Humira biosimilardailyvoiceplus.com
- DBoehringer Ingelheim acquires Swiss biotech Amal Therapeuticsdailyvoiceplus.com
- DBoehringer Ingelheim ordered to pay $542K in Pradaxa casedailyvoiceplus.com
- Boehringer Ingelheim attacks IBD collaborativelywestfaironline.com
- Boehringer Ingelheim files patent lawsuit against Durham companybizjournals.com
- Boehringer Ingelheim, Vanderbilt study cancer drugstheridgefieldpress.com
- Asthma inhaler prescription warningexpressandstar.com
- Boehringer Ingelheim cutting 725 jobs, including 50 in Ridgefieldwestfaironline.com
- Boehringer Ingelheim eliminating another 120 positions in Ridgefieldwestfaironline.com
- Boehringer Ingelheim and FDA ramp up anti-counterfeit medicine effortswestfaironline.com
- Hundreds of workers laid off in Boehringer Ingelheim cutswtnh.com
- Boehringer Ingelheim teams with Yale on biomedical fellowship programwestfaironline.com
- Boehringer Ingelheim begins next phase of liver disease studywestfaironline.com
- Boehringer Ingelheim cuts Connecticut jobs after sales fallMerced Sun-Star
- KSmart Inhaler Technology Market Size And Forecast 2021-2028 | Top Key Players – Teva Pharmaceutical Industries Limited, ResMed, Adherium, Novartis International AG, AstraZeneca, Boehringer Ingelheimksusentinel.com
- Exclusive: Boehringer Ingelheim USA President/CEO Jean-Michel Boers on firm’s 50th anniversary, future outlookwestfaironline.com
- Boehringer Ingelheim tops for femalestheridgefieldpress.com